You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) DEHYDRATED ALCOHOL


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing DEHYDRATED ALCOHOL excipient

DEHYDRATED ALCOHOL Market Analysis and Financial Projection Experimental

Dehydrated Alcohol in the Pharmaceutical Industry: Market Dynamics and Financial Trajectory

Overview of Dehydrated Alcohol

Dehydrated alcohol, also known as anhydrous ethanol, is a volatile chemical compound containing approximately 98% ethanol by volume. It is widely used in various industries, including pharmaceuticals, where it serves as a critical excipient.

Market Size and Growth

The dehydrated alcohol market is projected to grow significantly, driven largely by its increasing use in the pharmaceutical sector. By 2025, the dehydrated alcohol market is forecast to reach $15 billion, growing at a Compound Annual Growth Rate (CAGR) of 6% from 2020 to 2025[1].

Pharmaceutical Grade Dominance

In the pharmaceutical sector, dehydrated alcohol holds a substantial share, accounting for more than 35% of the market in 2019. It is used as a solvent, antiseptic, and disinfectant, and is crucial in the manufacture of sanitizers, hand sanitizers, and medical wipes. The surging demand for these products, particularly during the COVID-19 pandemic, has significantly boosted the growth of the dehydrated alcohol market[1].

Applications in Pharmaceuticals

Therapeutic Neurolysis

Dehydrated alcohol is used for therapeutic neurolysis of nerves or ganglia to relieve intractable chronic pain in conditions such as inoperable cancer and trigeminal neuralgia. It is injected proximate to nerve tissues and into spinal subarachnoid spaces to produce degeneration of nerve function[3].

Excipient Role

As an excipient, dehydrated alcohol plays a vital role in stabilizing, bulking up, and enhancing the therapeutic profile of pharmaceutical formulations. It is used to formulate medications that require long-term stability and to confer specific product attributes such as stability, biopharmaceutical profile, and patient acceptability[4].

Drivers of Market Growth

Increasing Health Spending

Global health spending has been on the rise, with real terms growth exceeding economic growth. For instance, between 2000 and 2017, global health spending grew by 3.9% annually, while the economy grew by 3.0% annually. This continuous spending on healthcare further boosts the demand for dehydrated alcohol in medical applications[1].

Regulatory Environment

Stringent regulations aimed at reducing the use of environment-polluting fossil fuels and the increasing demand from the food processing industry also drive the demand for dehydrated alcohol. For example, the U.S. Environmental Protection Agency's Clean Power Plan has encouraged the use of dehydrated ethanol as a cleaner fuel alternative[1].

Personal Care and Cosmetic Products

The surging demand for personal care and cosmetic products that contain dehydrated alcohol as an antimicrobial agent also contributes to market growth. This includes products like sanitizers, face wipes, and other skincare items[1].

Challenges and Constraints

Price Volatility

The production of dehydrated alcohol involves significant resources, leading to price volatility. For instance, the price of a 10-vial pack of injectable dehydrated alcohol increased dramatically from $1,300 to $10,000 in February 2020 due to production challenges and regulatory changes[1].

Transportation Risks

Dehydrated alcohol is volatile and flammable, posing challenges during transportation. This requires specialized handling and storage, adding to the overall cost and complexity of its use[1].

Regional Market Dynamics

North America

North America dominates the dehydrated alcohol market, with a share of more than 35% in 2019. The region's stringent environmental regulations and growing demand from the healthcare and food processing industries drive this dominance[1].

Asia Pacific and Europe

The Asia Pacific and European regions also show significant growth, driven by increasing health spending and the need for cleaner fuel alternatives. The easy availability and high yield of sugarcane in these regions further support the production of dehydrated alcohol from sugarcane[1].

Key Players and Strategies

The dehydrated alcohol market is consolidated, with top players such as Archer Daniel Midland Company, Butamax Advanced Biofuels, LLC, and Mitsubishi Chemical Corporation accounting for a significant share. These companies focus on technology launches, acquisitions, and research and development activities to maintain their market position[1].

Financial Trajectory

Revenue Growth

The alcohol excipients market, which includes dehydrated alcohol, was valued at $2.47 billion in 2023 and is expected to reach $3.85 billion by 2030, growing at a CAGR of 6.5% during the forecast period. This growth is largely driven by the pharmaceutical segment, which experienced tremendous growth during the COVID-19 pandemic[4].

Investment and Research

Huge government investments and research activities in healthcare further boost the financial trajectory of the dehydrated alcohol market. For example, U.S. health spending accounted for 17.7% of the nation's Gross Domestic Product in 2018, with healthcare spending growing by 4.6% to reach $3.6 trillion[1].

Conclusion

The market for dehydrated alcohol in the pharmaceutical industry is poised for significant growth, driven by increasing health spending, stringent environmental regulations, and the growing demand for personal care and cosmetic products. Despite challenges such as price volatility and transportation risks, the financial trajectory of dehydrated alcohol remains strong, with a projected market size of $15 billion by 2025.

Key Takeaways

  • Market Growth: The dehydrated alcohol market is expected to reach $15 billion by 2025, growing at a CAGR of 6%.
  • Pharmaceutical Use: Dehydrated alcohol is widely used in the pharmaceutical sector as a solvent, antiseptic, and disinfectant.
  • Health Spending: Increasing global health spending drives the demand for dehydrated alcohol in medical applications.
  • Regional Dominance: North America dominates the market, followed by the Asia Pacific and Europe.
  • Challenges: Price volatility and transportation risks are significant challenges in the market.

FAQs

What is dehydrated alcohol used for in the pharmaceutical industry?

Dehydrated alcohol is used as a solvent, antiseptic, and disinfectant in the pharmaceutical industry. It is also used for therapeutic neurolysis to relieve chronic pain.

Which region dominates the dehydrated alcohol market?

North America dominates the dehydrated alcohol market, followed by the Asia Pacific and Europe.

What are the key drivers of the dehydrated alcohol market?

Key drivers include increasing health spending, stringent environmental regulations, and the growing demand for personal care and cosmetic products.

What are the challenges associated with dehydrated alcohol?

Challenges include price volatility due to production complexities and transportation risks due to its volatile and flammable nature.

Who are the major players in the dehydrated alcohol market?

Major players include Archer Daniel Midland Company, Butamax Advanced Biofuels, LLC, and Mitsubishi Chemical Corporation.

Sources

  1. IndustryARC: Dehydrated Alcohol Market Size Report, 2020-2025.
  2. ACS Publications: Mechanistic Investigation of tert-Butanol's Impact on Protein Recovery.
  3. Drugs.com: Dehydrated Alcohol Injection: Package Insert / Prescribing Info.
  4. Maximize Market Research: Alcohol Excipients Market: Industry Analysis and Forecast.
  5. STXIP: Excipient Development for Pharmaceutical, Biotechnology, and Cosmetic Applications.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.